Haffkine Bio-Pharmaceutical Corporation Ltd.

Haffkine Bio-Pharmaceutical Corporation Ltd. (HBPCL) is a renowned Government of Maharashtra Undertaking, established in 1977. The company has a rich history dating back to Dr. Waldemar Mordecai Haffkine's mission to address the Cholera epidemic, spanning over 100 years. HBPCL is the world’s largest manufacturer of vaccines and pharmaceutical drugs, with a focus on expanding production activities to meet the growing demands for medicines and life-saving drugs. HBPCL operates as a fully owned Govt of Maharashtra Company, registered under Companies Act, 1956. The company plays a pivotal role in the development and production of a wide range of bacterial and viral vaccines, alongside pharmaceutical products, disinfectants, injectables, and more. Notably, the Antitoxin and Sera (ATS) department is engaged in the manufacturing of Antiserum against various diseases, including Tetanus, Diphtheria, and Snake and Scorpion Venoms. Moreover, HBPCL holds the distinction of introducing Scorpion Venom Antiserum for the first time in India in 1997, addressing a significant demand in the Konkan region. The subsidiary of HBPCL, Haffkine Ajintha Pharmaceuticals Ltd., further reinforces the corporation's pioneering role in the healthcare and pharmaceutical industries. The company's contributions extend to manufacturing Anti Rabies Serum (ARS) and supplying antisera to various states and Central Government Institutions at economical and affordable prices. In conclusion, Haffkine Bio-Pharmaceutical Corporation Ltd. stands as a prominent player in the healthcare, manufacturing, and pharmaceutical sectors, continuing its legacy of service to mankind initiated by Dr. Haffkine over a century ago.